Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd. (SHA:688076)
China flag China · Delayed Price · Currency is CNY
33.12
+0.31 (0.94%)
Mar 10, 2026, 10:14 AM CST

SHA:688076 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
-571.39749.08399.96591.88
Upgrade
Trading Asset Securities
-208-43.0187.13
Upgrade
Cash & Short-Term Investments
1,081779.39749.08442.98679.01
Upgrade
Cash Growth
38.70%4.05%69.10%-34.76%353.54%
Upgrade
Accounts Receivable
-539.21297.26251.29143.37
Upgrade
Other Receivables
-7.923.271.191.05
Upgrade
Receivables
-547.13300.53252.48144.41
Upgrade
Inventory
-584.04377.17323.48250.82
Upgrade
Other Current Assets
-94.9767.9833.5329.86
Upgrade
Total Current Assets
-2,0061,4951,0521,104
Upgrade
Property, Plant & Equipment
-1,8921,405988.47706.55
Upgrade
Long-Term Investments
-215.04117.594.5-
Upgrade
Goodwill
-156.34156.34156.34160.92
Upgrade
Other Intangible Assets
-108.19112.198.1888.57
Upgrade
Long-Term Deferred Tax Assets
-88.2746.6528.1316.63
Upgrade
Long-Term Deferred Charges
-203.241.0338.7715.66
Upgrade
Other Long-Term Assets
-409.4173.8465.4434.46
Upgrade
Total Assets
-5,0783,5472,5222,127
Upgrade
Accounts Payable
-159.7141.9387.6172.36
Upgrade
Accrued Expenses
-149.1286.1448.4943.99
Upgrade
Short-Term Debt
-1,044546.02318.7377.27
Upgrade
Current Portion of Long-Term Debt
-117.8940.08--
Upgrade
Current Portion of Leases
-9.795.291.473.64
Upgrade
Current Income Taxes Payable
-19.3511.475.37-
Upgrade
Current Unearned Revenue
-61.218.396.8526.17
Upgrade
Other Current Liabilities
-191.83134.0182.851.96
Upgrade
Total Current Liabilities
-1,753973.34551.32275.4
Upgrade
Long-Term Debt
-445.21286.49--
Upgrade
Long-Term Leases
-25.7517.18-2.74
Upgrade
Long-Term Unearned Revenue
-55.9931.4635.3221.74
Upgrade
Long-Term Deferred Tax Liabilities
-8.6110.1610.774.26
Upgrade
Other Long-Term Liabilities
-107.4339.31-14
Upgrade
Total Liabilities
-2,3961,358597.41318.14
Upgrade
Common Stock
-219.78213.18213.18213.18
Upgrade
Additional Paid-In Capital
-1,5981,3411,3191,318
Upgrade
Retained Earnings
-792.51495.37374.95277.82
Upgrade
Comprehensive Income & Other
-50.11120.233.332.2
Upgrade
Total Common Equity
3,1092,6602,1701,9101,811
Upgrade
Minority Interest
-21.9519.0414.66-2.61
Upgrade
Shareholders' Equity
3,1342,6822,1891,9251,809
Upgrade
Total Liabilities & Equity
-5,0783,5472,5222,127
Upgrade
Total Debt
2,5841,642895.07320.1983.65
Upgrade
Net Cash (Debt)
-1,503-863.06-145.98122.79595.36
Upgrade
Net Cash Growth
----79.38%-
Upgrade
Net Cash Per Share
-4.78-2.81-0.490.412.21
Upgrade
Filing Date Shares Outstanding
316.05307.69298.46298.46298.46
Upgrade
Total Common Shares Outstanding
316.05307.69298.46298.46298.46
Upgrade
Working Capital
-252.82521.43501.15828.71
Upgrade
Book Value Per Share
9.848.657.276.406.07
Upgrade
Tangible Book Value
2,7792,3961,9021,6561,562
Upgrade
Tangible Book Value Per Share
8.797.796.375.555.23
Upgrade
Buildings
-516.19504.29476.24376.08
Upgrade
Machinery
-1,6031,123652.13529
Upgrade
Construction In Progress
-339.92185.96180.1134.85
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.